Revista Española de Cardiología (English Edition) Revista Española de Cardiología (English Edition)
Section: Letters to the Editor
3D Printing in Revista Española de Cardiología: Just a Passing Fad?
Gorka Gomez, Israel Valverde
Rev Esp Cardiol. 2019;72:275
DOI: http://dx.doi.org/10.1016/j.rec.2018.10.012
Full text - PDF
Antiarrhythmic Drugs Are not the Only Option in Electrical Storm: Extracorporeal Membrane Oxygenation as a Life-saving Alternative. Response
Jorge García Carreño, Iago Sousa-Casasnovas, Francisco Fernández Avilés, Manuel Martínez Sellés
Rev Esp Cardiol. 2019;72:185
DOI: http://dx.doi.org/10.1016/j.rec.2018.08.020
Full text - PDF
Antiarrhythmic Drugs Are not the Only Option in Electrical Storm: Extracorporeal Membrane Oxygenation as a Life-saving Alternative
Raphaël P. Martins, Erwan Flecher, Solène Le Pennec-Prigent, Vincent Galand
Rev Esp Cardiol. 2019;72:184
DOI: http://dx.doi.org/10.1016/j.rec.2018.08.007
Full text - PDF
Prophylaxis of Infective Endocarditis in Dentistry: Analysis of the Situation After Almost a Decade of Clinical Practice Guidelines
Iria Silva Conde, Francisco Torres-Saura, Alberto Alperi García, Jesús María de la Hera Galarza
Rev Esp Cardiol. 2019;72:95
DOI: http://dx.doi.org/10.1016/j.rec.2018.07.013
Full text - PDF
Use of High-potency Statins After Percutaneous Revascularization
Mercedes Millán Gómez, Macarena Cano García, Carlos Sánchez González, Manuel Jiménez Navarro
Rev Esp Cardiol. 2019;72:98
DOI: http://dx.doi.org/10.1016/j.rec.2018.08.006
Full text - PDF
Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response
Maria Mahmood, Gregory Y.H. Lip
Rev Esp Cardiol. 2019;72:97-8
DOI: http://dx.doi.org/10.1016/j.rec.2018.08.002
Full text - PDF
Use of Oral Anticoagulation for Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays?
Jun Li, Xinyue Liu, Sulin Zheng, Yuli Huang
Rev Esp Cardiol. 2019;72:96-7
DOI: http://dx.doi.org/10.1016/j.rec.2018.07.007
Full text - PDF
Prophylaxis of Infective Endocarditis in Dentistry: Analysis of the Situation After Almost a Decade of Clinical Practice Guidelines. Response
Paula Anguita, Juan C. Castillo, Manuela Herrera, Manuel Anguita
Rev Esp Cardiol. 2019;72:96
DOI: http://dx.doi.org/10.1016/j.rec.2018.07.018
Full text - PDF
Cost-effectiveness of Evolocumab
Carlos Escobar, Vivencio Barrios
Rev Esp Cardiol. 2018;71:1089
DOI: http://dx.doi.org/10.1016/j.rec.2018.04.028
Full text - PDF
Cost-effectiveness of Evolocumab. Response
Antonio Olry de Labry Lima, Antonio Matas Hoces, Emilio Jesús Alegre del Rey, Vicente Gimeno Ballester
Rev Esp Cardiol. 2018;71:1090
DOI: http://dx.doi.org/10.1016/j.rec.2018.05.031
Full text - PDF
Antiplatelet Bridging Is an Option During Perioperative and Periprocedural Management of Antithrombotic Therapy
Santiago de Dios
Rev Esp Cardiol. 2018;71:877
DOI: http://dx.doi.org/10.1016/j.rec.2018.05.025
Full text - PDF
Cancer and Acute Coronary Syndrome. A Close, but Complicated Relationship. Response
Alberto Cordero, Vicente Bertomeu-González, Julio Núñez, Vicente Bertomeu-Martínez
Rev Esp Cardiol. 2018;71:880-1
DOI: http://dx.doi.org/10.1016/j.rec.2018.05.033
Full text - PDF
Cancer and Acute Coronary Syndrome. A Close but Complicated Relationship
Gerard Oristrell
Rev Esp Cardiol. 2018;71:879-80
DOI: http://dx.doi.org/10.1016/j.rec.2018.06.025
Full text - PDF
Antithrombotic Therapy and Surgery: From Consensus to Clinical Practice. Response to Related Letters
David Vivas, Jose Luis Ferreiro, Inmaculada Roldán
Rev Esp Cardiol. 2018;71:879
DOI: http://dx.doi.org/10.1016/j.rec.2018.05.032
Full text - PDF
Management of Anticoagulants in Procedures That Can Cause Bleeding
Enrique Martín-Rioboó, Cristina Martín-Mañero, Paula Medina-Durán, Luis Angel Pérula-de Torres
Rev Esp Cardiol. 2018;71:878
DOI: http://dx.doi.org/10.1016/j.rec.2018.05.024
Full text - PDF
Phenotype-modifying Factors in Hypertrophic Cardiomyopathy
Javier Limeres Freire
Rev Esp Cardiol. 2018;71:770
DOI: http://dx.doi.org/10.1016/j.rec.2018.03.021
Full text - PDF
Phenotype-modifying Factors in Hypertrophic Cardiomyopathy. Response
Inmaculada Pérez-Sánchez, María Sabater-Molina, Carmen Muñoz-Esparza, Juan Ramón Gimeno-Blanes
Rev Esp Cardiol. 2018;71:770-1
DOI: http://dx.doi.org/10.1016/j.rec.2018.04.023
Full text - PDF
Soria Cardioprotegida. The First Spanish Program for the Prevention and Integral Treatment of Sudden Cardiac Death
Juan Ruiz-García, Irene Canal-Fontcuberta, Alberto Caballero-García, Juan Manuel Ruiz-Liso
Rev Esp Cardiol. 2018;71:689
DOI: http://dx.doi.org/10.1016/j.rec.2018.05.008
Full text - PDF
Soria Cardioprotegida. The First Spanish Program for the Prevention and Integral Treatment of Sudden Cardiac Death. Response
Pablo Loma-Osorio, Ramon Brugada
Rev Esp Cardiol. 2018;71:690
DOI: http://dx.doi.org/10.1016/j.rec.2018.05.004
Full text - PDF
Update to the Consensus Document on Clinical Use of the Polypill: New Dose Containing Atorvastatin 40 mg
José Ramón González-Juanatey
Rev Esp Cardiol. 2018;71:595-6
DOI: http://dx.doi.org/10.1016/j.rec.2018.04.004
Full text - PDF
Cookies
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.
Cookies policy
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.